184 related articles for article (PubMed ID: 18483172)
1. Effects of cardiotonic steroids on dermal collagen synthesis and wound healing.
El-Okdi N; Smaili S; Raju V; Shidyak A; Gupta S; Fedorova L; Elkareh J; Periyasamy S; Shapiro AP; Kahaleh MB; Malhotra D; Xie Z; Chin KV; Shapiro JI
J Appl Physiol (1985); 2008 Jul; 105(1):30-6. PubMed ID: 18483172
[TBL] [Abstract][Full Text] [Related]
2. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia.
Oselkin M; Tian D; Bergold PJ
Neurosci Lett; 2010 Apr; 473(2):67-71. PubMed ID: 19822191
[TBL] [Abstract][Full Text] [Related]
3. Depth of the Steroid Core Location Determines the Mode of Na,K-ATPase Inhibition by Cardiotonic Steroids.
Tverskoi AM; Poluektov YM; Klimanova EA; Mitkevich VA; Makarov AA; Orlov SN; Petrushanko IY; Lopina OD
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948068
[TBL] [Abstract][Full Text] [Related]
4. Na/K-ATPase signaling regulates collagen synthesis through microRNA-29b-3p in cardiac fibroblasts.
Drummond CA; Hill MC; Shi H; Fan X; Xie JX; Haller ST; Kennedy DJ; Liu J; Garrett MR; Xie Z; Cooper CJ; Shapiro JI; Tian J
Physiol Genomics; 2016 Mar; 48(3):220-9. PubMed ID: 26702050
[TBL] [Abstract][Full Text] [Related]
5. Periplocin promotes wound healing through the activation of Src/ERK and PI3K/Akt pathways mediated by Na/K-ATPase.
Chen L; Jiang P; Li J; Xie Z; Xu Y; Qu W; Feng F; Liu W
Phytomedicine; 2019 Apr; 57():72-83. PubMed ID: 30668325
[TBL] [Abstract][Full Text] [Related]
6. Activation of c-SRC underlies the differential effects of ouabain and digoxin on Ca(2+) signaling in arterial smooth muscle cells.
Zulian A; Linde CI; Pulina MV; Baryshnikov SG; Papparella I; Hamlyn JM; Golovina VA
Am J Physiol Cell Physiol; 2013 Feb; 304(4):C324-33. PubMed ID: 23195071
[TBL] [Abstract][Full Text] [Related]
7. Cardiotonic steroids stimulate glycogen synthesis in human skeletal muscle cells via a Src- and ERK1/2-dependent mechanism.
Kotova O; Al-Khalili L; Talia S; Hooke C; Fedorova OV; Bagrov AY; Chibalin AV
J Biol Chem; 2006 Jul; 281(29):20085-94. PubMed ID: 16714287
[TBL] [Abstract][Full Text] [Related]
8. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
Schoner W; Scheiner-Bobis G
Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
[TBL] [Abstract][Full Text] [Related]
9. Effects of Periploca forrestii Schltr on wound healing by Src meditated Mek/Erk and PI3K/Akt signals.
Li J; Chen L; Xu J; Xie Z; Xu Y; Jiang P; Duan B; Huang X; Feng F; Liu W
J Ethnopharmacol; 2019 Jun; 237():116-127. PubMed ID: 30905787
[TBL] [Abstract][Full Text] [Related]
10. Time- and dose dependent actions of cardiotonic steroids on transcriptome and intracellular content of Na
Klimanova EA; Tverskoi AM; Koltsova SV; Sidorenko SV; Lopina OD; Tremblay J; Hamet P; Kapilevich LV; Orlov SN
Sci Rep; 2017 Mar; 7():45403. PubMed ID: 28345607
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation.
Touza NA; Pôças ES; Quintas LE; Cunha-Filho G; Santos ML; Noël F
Life Sci; 2011 Jan; 88(1-2):39-42. PubMed ID: 21047518
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin.
Tian J; Shidyak A; Periyasamy SM; Haller S; Taleb M; El-Okdi N; Elkareh J; Gupta S; Gohara S; Fedorova OV; Cooper CJ; Xie Z; Malhotra D; Bagrov AY; Shapiro JI
Hypertension; 2009 Dec; 54(6):1313-20. PubMed ID: 19884563
[TBL] [Abstract][Full Text] [Related]
13. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
Schoner W; Scheiner-Bobis G
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
[TBL] [Abstract][Full Text] [Related]
14. Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy.
Elkareh J; Kennedy DJ; Yashaswi B; Vetteth S; Shidyak A; Kim EG; Smaili S; Periyasamy SM; Hariri IM; Fedorova L; Liu J; Wu L; Kahaleh MB; Xie Z; Malhotra D; Fedorova OV; Kashkin VA; Bagrov AY; Shapiro JI
Hypertension; 2007 Jan; 49(1):215-24. PubMed ID: 17145984
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of peripheral blood mononuclear cell proliferation by cardiac glycosides.
Gentile DA; Henry J; Katz AJ; Skoner DP
Ann Allergy Asthma Immunol; 1997 May; 78(5):466-72. PubMed ID: 9164359
[TBL] [Abstract][Full Text] [Related]
16. Ouabain attenuates cardiotoxicity induced by other cardiac steroids.
Nesher M; Shpolansky U; Viola N; Dvela M; Buzaglo N; Cohen Ben-Ami H; Rosen H; Lichtstein D
Br J Pharmacol; 2010 May; 160(2):346-54. PubMed ID: 20423344
[TBL] [Abstract][Full Text] [Related]
17. Endogenous cardiac glycosides, a new class of steroid hormones.
Schoner W
Eur J Biochem; 2002 May; 269(10):2440-8. PubMed ID: 12027881
[TBL] [Abstract][Full Text] [Related]
18. Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway.
Arnaud-Batista FJ; Costa GT; Oliveira IM; Costa PP; Santos CF; Fonteles MC; Uchôa DE; Silveira ER; Cardi BA; Carvalho KM; Amaral LS; Pôças ES; Quintas LE; Noël F; Nascimento NR
Am J Physiol Renal Physiol; 2012 Apr; 302(8):F959-66. PubMed ID: 22237798
[TBL] [Abstract][Full Text] [Related]
19. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
Schoner W; Scheiner-Bobis G
Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
[TBL] [Abstract][Full Text] [Related]
20. Regulation of myofibroblast differentiation by cardiac glycosides.
La J; Reed EB; Koltsova S; Akimova O; Hamanaka RB; Mutlu GM; Orlov SN; Dulin NO
Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(9):L815-23. PubMed ID: 26851261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
